SCHEMBL175017

SCHEMBL175017

N#Cc1ccccc1NC(=O)Nc1cccc2c1CCN2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.56
KDM4E B2RXH2 5/20 0.56
ALDH1A1 P00352 4/20 0.51
GLA P06280 1/20 0.51
ALOX15 P16050 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CYP1A2 P05177 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CXCR2 P25025 1/20 0.48
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
HPGD P15428 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
TSHR P16473 1/20 0.42
PDK1 Q15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175067 0.85 MAPT (0.52) GAAKDM4EALDH1A1GLASMN1; SMN2
SCHEMBL175596 0.83 MEN1 (0.56) GAAKDM4EALDH1A1ALOX15HSD17B10
SCHEMBL4569778 0.82 MEN1 (0.53) GAAKDM4EALDH1A1SMN1; SMN2CXCR2
SCHEMBL175199 0.81 HTT (0.51) GAAALDH1A1CXCR2KMT2AMEN1
SCHEMBL174238 0.81 DDX3X (0.52) GAAKDM4EALDH1A1ALOX15HSD17B10
SCHEMBL257377 0.79 GAA (0.45) GAAKDM4EALDH1A1CYP1A2L3MBTL1
SCHEMBL173797 0.78 MEN1 (0.54) KDM4EALDH1A1CYP1A2SMN1; SMN2CXCR2
SCHEMBL173758 0.78 SMN1; SMN2 (0.53) GAAKDM4EALDH1A1HSD17B10SMN1; SMN2
SCHEMBL174930 0.76 RAB9A (0.52) GAAKDM4EALDH1A1ALOX15HSD17B10
SCHEMBL174936 0.76 MEN1 (0.51) ALDH1A1SMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed